JAMA : the journal of the American Medical Association
-
Tumor recurrence is a major issue for patients with hepatocellular carcinoma (HCC) following curative liver resection. ⋯ Nucleoside analogue use was associated with a lower risk of HCC recurrence among patients with HBV-related HCC after liver resection.